Status:
COMPLETED
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
Lead Sponsor:
Corfu General Hospital
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is an interventional double-blind randomized controlled trial, to investigate the short and long-term effects of a supervised exercise training program in patients with IPF, depending on alternat...
Detailed Description
The investigators hypothesize that PR service with supplemented oxygen supply regardless of hypoxemia may have significantly better short-term effects in patients with IPF. The study will take place i...
Eligibility Criteria
Inclusion
- diagnosis of IPF based on current established criteria
- no exacerbation previous 3 months
- no participation in such program previous 3 months.
- If on treatment with pirfenidone or nintedanib, this will be recorded and patient should be on treatment for at least 3-6 months to achieve stable state.
Exclusion
- \- concomitant diagnosis of congestive heart failure and lung cancer.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03326089
Start Date
June 1 2017
End Date
August 28 2023
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corfu General Hospital
Corfu, Greece, 49100